Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK7 | P49862 | 2/20 | 0.59 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CPB1 | P15086 | 1/20 | 0.54 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.54 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28902002 | 1.00 | KLK7 (0.59) | KLK7KLK5MAPTABCB1FOLH1 | |
| SCHEMBL29072109 | 0.91 | KLK7 (0.60) | KLK7KLK5MAPTABCB1FOLH1 | |
| SCHEMBL29072115 | 0.91 | KLK7 (0.60) | KLK7KLK5MAPTABCB1FOLH1 | |
| SCHEMBL22972745 | 0.90 | KLK7 (0.59) | KLK7KLK5MAPTABCB1FOLH1 | |
| SCHEMBL17309872 | 0.89 | MAPT (0.68) | KLK7KLK5MAPTABCB1FOLH1 | |
| SCHEMBL1303931 | 0.89 | MAPT (0.68) | KLK7KLK5MAPTABCB1FOLH1 | |
| SCHEMBL15976615 | 0.89 | CA1 (0.66) | FOLH1CA1CA2CPB1CPB2 | |
| SCHEMBL9389258 | 0.89 | FOLH1 (0.61) | FOLH1CA1CA2CPB1CPB2 | |
| SCHEMBL29460388 | 0.89 | KLK7 (0.61) | KLK7KLK5MAPTABCB1FOLH1 | |
| SCHEMBL20530051 | 0.89 | KLK7 (0.53) | KLK7KLK5MAPTABCB1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114364405-B | Prostate Specific Membrane Antigen (PSMA) inhibitors as diagnostic and radionuclide therapeutics | 五一一制药股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-114364405-A | Prostate Specific Membrane Antigen (PSMA) inhibitors as diagnostic agents and radionuclide therapeutics | 五一一制药股份有限公司 | 2022-04-15 | — | — | CN | disclosed |